DEFINITY

This brand name is authorized in Canada, New Zealand, United States

Active ingredients

The drug DEFINITY contains one active pharmaceutical ingredient (API):

1 Perflutren UNII CK0N3WH0SR - PERFLUTREN

When used in conjunction with diagnostic ultrasound, perflutren provides opacification of cardiac chambers, improvement in delineation of endocardial borders, enhancement of the Doppler signal, and visualisation of wall motion and blood flow within the heart. Read about Perflutren

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
DEFINITY Suspension for injection	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
V08DA04		V Various → V08 Contrast media → V08D Ultrasound contrast media → V08DA Ultrasound contrast media
Discover more medicines within V08DA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02243173
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 13174
Country: US	FDA, National Drug Code	Identifier(s): 11994-011, 11994-017